1. SN-38 Sensitizes BRCA-Proficient Ovarian Cancers to PARP Inhibitors through Inhibiting Homologous Recombination Repair
   Shengbin Lin et al, 2022, Disease Markers CrossRef
2. Potential Alternative Therapeutic Modalities for Management Head and Neck Squamous Cell Carcinoma: A Review
   Keihan Afshari et al, 2023, Cancer Control CrossRef